Quantitative Chemoproteomics Reveals Dopamine's Protective Modification of Tau

Dopamine (DA) is one of the most important neurotransmitters. Its oxidation leads to electrophilic quinone, which covalently modifies nucleophilic residues in proteins, resulting in ‘dopamination’. Individual dopaminated proteins have been studied, most of which were functionally damaged by dopamination. Here, we developed a quantitative chemoproteomic strategy to site-specifically measure proteins’ dopamination. More than 6,000 dopamination sites were quantified and IC50 values for 63 hyper-sensitive sites were measured. Among them, hyper-sensitive dopamination of two cysteines in microtubule-associated protein Tau were biochemically validated and functionally characterized to prevent Tau’s amyloid fibrillation and promote Tau-mediated assembly of microtubules. In addition, endogenous dopamination of Tau in mouse brain was detected through targeted mass spectrometry analysis. Our study not only provided the global portrait of dopamination, but also discovered a protective role of DA in regulating the function of Tau, which will enhance our understanding of physiological and pathological functions of DA in human brain.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-18
DOI
https://doi.org/10.5281/zenodo.14511271
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quantitative Chemoproteomics Reveals Dopamine's Protective Modification of Tau

Zenodo (CERN European Organization for Nuclear Research)
Alzheimer's disease research and treatments
article

Quantitative Chemoproteomics Reveals Dopamine's Protective Modification of Tau

article en

Abstract

Dopamine (DA) is one of the most important neurotransmitters. Its oxidation leads to electrophilic quinone, which covalently modifies nucleophilic residues in proteins, resulting in ‘dopamination’. Individual dopaminated proteins have been studied, most of which were functionally damaged by dopamination. Here, we developed a quantitative chemoproteomic strategy to site-specifically measure proteins’ dopamination. More than 6,000 dopamination sites were quantified and IC50 values for 63 hyper-sensitive sites were measured. Among them, hyper-sensitive dopamination of two cysteines in microtubule-associated protein Tau were biochemically validated and functionally characterized to prevent Tau’s amyloid fibrillation and promote Tau-mediated assembly of microtubules. In addition, endogenous dopamination of Tau in mouse brain was detected through targeted mass spectrometry analysis. Our study not only provided the global portrait of dopamination, but also discovered a protective role of DA in regulating the function of Tau, which will enhance our understanding of physiological and pathological functions of DA in human brain.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 60%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Quantitative Chemoproteomics Reveals Dopamine's Protective Modification of Tau · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS